首页> 外国专利> METHOD FOR OBTAINING SODIUM CARBOXYMETHYL CELLULOSE AND GOSSYPOL COPOLYMER AND ITS APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH AUTISTIC DISORDERS AND COGNITIVE DISORDERS

METHOD FOR OBTAINING SODIUM CARBOXYMETHYL CELLULOSE AND GOSSYPOL COPOLYMER AND ITS APPLICATION IN COMPLEX THERAPY OF PATIENTS WITH AUTISTIC DISORDERS AND COGNITIVE DISORDERS

机译:羧甲基纤维素钠和果糖脂共聚物的制备方法及其在自闭症和认知障碍综合治疗中的应用

摘要

1. A method of obtaining a copolymer of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 and gossypol of the formula (I):! ! where a: b: c = 1: (3-6) :( 5-7),! n = 40-50; ! molecular weight 120000-130000, including the interaction of an aqueous solution of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 with an aqueous solution of iodic acid or sodium periodate, followed by isolation of the carboxymethyl cellulose dialdehyde, treatment of the resulting product with gossypol or gossypolacetic acid, then an aqueous alkali solution and isolation of the target product by precipitation with an organic solvent, characterized in that the interaction of an aqueous solution of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 with an aqueous solution of iodic acid or sodium periodate is carried out while passing through the reaction solution of carbon dioxide until the pH of the solution is 3.0-4.5. ! 2. The use of a copolymer of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 and gossypol of the formula (I)! ! where a: b: c = 1: (3-6) :( 5-7),! n = 40-50; ! molecular weight of 120,000-130000; ! in the complex treatment of patients with autistic disorders and cognitive impairment. ! 3. The use according to claim 2, where the copolymer of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 and gossypol of formula (I) is obtained by the method according to claim 1. ! 4. The use according to claim 2 or 3, where the copolymer of sodium carboxymethyl cellulose with a degree of substitution of 0.35-0.80 and gossypol of the formula (1) is used in combination with a means for treating cognitive disorders selected from one or more antipsychotics, antidepressants, anticonvulsants or combinations thereof. ! 5. The pharmaceutical composition intended for use in the treatment of pa
机译:1.一种获得取代度为0.35-0.80的羧甲基纤维素钠与式(I)的棉酚的共聚物的方法: !其中a:b:c = 1:(3-6):( 5-7),! n = 40-50; !分子量为120000-130000,包括取代度为0.35-0.80的羧甲基纤维素钠水溶液与碘酸或高碘酸钠水溶液的相互作用,然后分离羧甲基纤维素二醛,处理所得产物产物用棉酚或棉酚乙酸,然后用碱水溶液洗涤,并通过用有机溶剂沉淀分离目标产物,其特征在于羧甲基纤维素钠水溶液的取代度为0.35-0.80,与水溶液相互作用碘酸或高碘酸钠的溶液在通过二氧化碳的反应溶液的同时进行,直到溶液的pH为3.0-4.5。 ! 2.取代度为0.35-0.80的羧甲基纤维素钠与式(I)的棉酚的共聚物的用途! !其中a:b:c = 1:(3-6):( 5-7),! n = 40-50; !分子量为120,000-130000; !在自闭症和认知障碍患者的综合治疗中。 ! 3.根据权利要求2的用途,其中通过权利要求1的方法获得取代度为0.35-0.80的羧甲基纤维素钠和式(I)的棉酚的共聚物。 4.根据权利要求2或3的用途,其中具有0.35-0.80的取代度的羧甲基纤维素钠和式(1)的棉酚的共聚物与选自以下一种或多种的认知障碍的治疗方法结合使用:更多抗精神病药,抗抑郁药,抗惊厥药或其组合。 ! 5.打算用于治疗pa的药物组合物

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号